Of the subjects, 52.3% of participants were advised to undergo prostate cancer examination and PSA testing by the urologist, whereas 26.7% of subjects mentioned that the primary health care physicians had discussed the benefits and harms of PSA testing with them. Here, KLK3 is linked to prostate carcinoma.